Duquesne - Investments & Acquisitions

Show Real Data Duquesne Investments
See all Recent Investments
Date Company Round Amount Co-investors
2007-07-13AgensysSeries D$41.3MAlta Partners, Bear Stearns, HBM Healthcare Investments, HBM Partners, JAFCO Life Science Investment, LODH Private Equity Partners, Nextech Venture, OrbiMed Advisors, Queensland BioCapital Funds, and Tekla Capital Management
2006-11-09Dilithium NetworksSeries D$16.77MAttractor Investment Management, CM Capital, Deutsche Bank, Franklin Templeton, Galleon Group, Motorola Solutions Venture Capital, and U.S. Venture Partners
2005-08-05ReplidyneUnattributed VC - IV$62.5MAisling Capital, Healthcare Investment Partners, Lumira Ventures, Morgenthaler Ventures, Och-Ziff Capital Management Group, Perseus, Quintiles Transnational, Sequel Venture Partners, Temasek, and TPG Growth
2005-04-13ViroPharmaPIPE - II$75MAlexandra Investment Management, Angelo Gordon, Baker Brothers Investments, BayStar Capital, Centaur Classic Convertible Arbitrage Fund Ltd, Centaur Performance Group., ClearBridge Investments, Hamilton Investment Partners, Hamilton Multi-Strategy Master Fund Lp, Heights Capital Management, Highbridge Capital Management, Northwestern Mutual, Perceptive Advisors, Polygon Investment Partners LLP, Promethean Asset Management, Quogue Capital, QVT Financial, Suttonbrook Capital Management, and TQA Investors
2005-02-18FibroGenUnattributed VC - II$100MAdage Capital Management, Apothecary Capital, Astellas Pharma, Bain Capital Public Equity, Bio Fund Management, Goldman Sachs, Janus Capital Group, Merlin Biomed Group, Och-Ziff Capital Management Group, Sigma Capital Group, SMBC Capital, T. Rowe Price, and The Rosewood Corporation
See all 7 investments